Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Harrison

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Proceedings of the Royal Society of Medicine|December 9, 2009
Discussion on Proprietary and Secret RemediesE F Harrison
Long Range Planning|November 5, 1991
Strategic control at the CEO levelE F Harrison
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1970
Comparison of the protective properties of soterenol and isoproterenol against endotoxin lethalityP Zwadyk, E F Harrison
Seminars in Oncology|December 1, 1982
The anticancer spectrum of ifosfamideH L Hunter, E F Harrison
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1972
Immunosuppressive properties of cyclophosphamide analoguesE F Harrison, M E Fuquay
Canadian Journal of Microbiology|September 1, 1974
Haloprogin: mode of action studies in Candida albicansE F Harrison, W A Zygmunt
Seminars in Oncology|March 1, 1983
Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in ratsE F Harrison, M E Fuquay, H L Hunter
Infection and Immunity|February 1, 1975
Antigenic response to topically applied proteinsE F Harrison, M E Fuquay, W A Zygmunt
European Journal of Cancer & Clinical Oncology|January 1, 1982
Protective effect of N-acetylcysteine on the urotoxicity produced by oxazaphosphorine without interference with anticancer activityL R Morgan, P J Donley, E F Harrison, et al.
Seminars in Oncology|December 1, 1982
The control of ifosfamide-induced hematuria with N-acetylcysteine in patients with advanced carcinoma of the lungL R Morgan, P J Donley, E F Harrison, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Proceedings of the Royal Society of Medicine|December 9, 2009
Discussion on Proprietary and Secret RemediesE F Harrison
Long Range Planning|November 5, 1991
Strategic control at the CEO levelE F Harrison
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1970
Comparison of the protective properties of soterenol and isoproterenol against endotoxin lethalityP Zwadyk, E F Harrison
Seminars in Oncology|December 1, 1982
The anticancer spectrum of ifosfamideH L Hunter, E F Harrison
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1972
Immunosuppressive properties of cyclophosphamide analoguesE F Harrison, M E Fuquay
Canadian Journal of Microbiology|September 1, 1974
Haloprogin: mode of action studies in Candida albicansE F Harrison, W A Zygmunt
Seminars in Oncology|March 1, 1983
Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in ratsE F Harrison, M E Fuquay, H L Hunter
Infection and Immunity|February 1, 1975
Antigenic response to topically applied proteinsE F Harrison, M E Fuquay, W A Zygmunt
European Journal of Cancer & Clinical Oncology|January 1, 1982
Protective effect of N-acetylcysteine on the urotoxicity produced by oxazaphosphorine without interference with anticancer activityL R Morgan, P J Donley, E F Harrison, et al.
Seminars in Oncology|December 1, 1982
The control of ifosfamide-induced hematuria with N-acetylcysteine in patients with advanced carcinoma of the lungL R Morgan, P J Donley, E F Harrison, et al.
Pageof 3